登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Summary of post-baseline laboratory abnormalities.
Summary of post-baseline laboratory abnormalities.
收藏
NIAID Data Ecosystem
2026-03-10 收录
HIV药物安全性监测
实验室异常
数据链接：
https://figshare.com/articles/dataset/Summary_of_post-baseline_laboratory_abnormalities_/7540022
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Summary of post-baseline laboratory abnormalities.
应用场景：
创建时间：
2019-01-02
相关数据集
Adverse events during the treatment period.
HIV药物安全性监测
临床试验不良事件
Adverse events during the treatment period.
NIAID Data Ecosystem
6
0
Adverse events (frequency) in healthy volunteers.
HIV药物安全性监测
临床试验不良事件
Adverse events (frequency) in healthy volunteers.
Figshare
2019-03-27 更新
2
0
Supplementary Material - ECZTEND Interim Analysis Manuscript (2 years tralokinumab treatment)
特应性皮炎疗效评估
HIV药物安全性监测
Supplementary Information to accompany and support the manuscript: Long-term 2-Year Safety and Efficacy of Tralokinumab in Adults with Moderate-to-severe Atopic Dermatitis: Interim Analysis of the ECZ
Mendeley Data
2
0
Drug-related, Treatment-Emergent Adverse Events (TEAEs) that occurred during the Open-Label Treatment Period.
HIV药物安全性监测
临床试验不良事件
Drug-related, Treatment-Emergent Adverse Events (TEAEs) that occurred during the Open-Label Treatment Period.
Figshare
2019-09-23 更新
4
0
Prevalence rate of concurrent use of GI protection for users of NSAIDs or low-dose ASA before hospital admission, and for new patients starting NSAID or low-dose ASA during hospital stay.
HIV药物安全性监测
胃肠道保护剂联合用药
Data are given in numbers, percentages and with 95% confidence intervals unless otherwise indicated.
NIAID Data Ecosystem
2
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
